Acknowledgement
This work was supported by a Research Grant of Andong Nation University
References
- Jung KW, Won YJ, Hong S, Kong HJ, Lee ES. Prediction of cancer incidence and mortality in Korea, 2020. Cancer Res Treat 2020; 52(2): 351-358. https://doi.org/10.4143/crt.2020.203
- Chu SK, Seo EY, Kim WK, Kang NE. Effect of cyanidin on cell motility and invasion in MDA-MB-231 human breast cancer cells. Korean J Nutr 2008; 41(8): 711-717.
- Block KI, Gyllenhaal C, Tripathy D, Freels S, Mead MN, Block PB, et al. Survival impact of integrative cancer care in advanced metastatic breast cancer. Breast J 2009; 15(4): 357-366. https://doi.org/10.1111/j.1524-4741.2009.00739.x
- Gupta GP, Minn AJ, Kang Y, Siegel PM, Serganova I, Cordon-Cardo C, et al. Identifying site-specific metastasis genes and functions. Cold Spring Harb Symp Quant Biol 2005; 70: 149-158. https://doi.org/10.1101/sqb.2005.70.018
- Kwon HS, Oh SM, Kim JK. Glabridin, a functional compound of liquorice, attenuates colonic inflammation in mice with dextran sulphate sodium-induced colitis. Clin Exp Immunol 2008; 151(1): 165-173. https://doi.org/10.1111/j.1365-2249.2007.03539.x
- Carmeli E, Fogelman Y. Antioxidant effect of polyphenolic glabridin on LDL oxidation. Toxicol Ind Health 2009; 25(4-5): 321-324. https://doi.org/10.1177/0748233709103034
- Liu K, Pi F, Zhang H, Ji J, Xia S, Cui F, et al. Metabolomics analysis to evaluate the anti-inflammatory effects of polyphenols: glabridin reversed metabolism change caused by LPS in RAW 264.7 cells. J Agric Food Chem 2017; 65(29): 6070-6079. https://doi.org/10.1021/acs.jafc.7b01692
- Yokota T, Nishio H, Kubota Y, Mizoguchi M. The inhibitory effect of glabridin from licorice extracts on melanogenesis and inflammation. Pigment Cell Res 1998; 11(6): 355-361. https://doi.org/10.1111/j.1600-0749.1998.tb00494.x
- Simmler C, Pauli GF, Chen SN. Phytochemistry and biological properties of glabridin. Fitoterapia 2013; 90: 160-184. https://doi.org/10.1016/j.fitote.2013.07.003
- Xu R, Rai A, Chen M, Suwakulsiri W, Greening DW, Simpson RJ. Extracellular vesicles in cancer - implications for future improvements in cancer care. Nat Rev Clin Oncol 2018; 15(10): 617-638. https://doi.org/10.1038/s41571-018-0036-9
- Becker A, Thakur BK, Weiss JM, Kim HS, Peinado H, Lyden D. Extracellular vesicles in cancer: cell-to-cell mediators of metastasis. Cancer Cell 2016; 30(6): 836-848. https://doi.org/10.1016/j.ccell.2016.10.009
- Im EJ, Lee CH, Moon PG, Rangaswamy GG, Lee B, Lee JM, et al. Sulfisoxazole inhibits the secretion of small extracellular vesicles by targeting the endothelin receptor A. Nat Commun 2019; 10(1): 1387. https://doi.org/10.1038/s41467-019-09387-4
- Lee SJ, Lee J, Jung JH, Park HY, Moon PG, Chae YS, et al. Exosomal Del-1 as a potent diagnostic marker for breast cancer: prospective cohort study. Clin Breast Cancer 2021; 21(6): e748-e756. https://doi.org/10.1016/j.clbc.2021.02.002
- Doonan F, Cotter TG. Morphological assessment of apoptosis. Methods 2008; 44(3): 200-204. https://doi.org/10.1016/j.ymeth.2007.11.006
- Kang SW. Role of reactive oxygen species in cell death pathways. Hanyang Med Rev 2013; 33(2): 77-82. https://doi.org/10.7599/hmr.2013.33.2.77
- Liotta LA, Kleinerman J, Catanzaro P, Rynbrandt D. Degradation of basement membrane by murine tumor cells. J Natl Cancer Inst 1977; 58(5): 1427-1431. https://doi.org/10.1093/jnci/58.5.1427
- Goh PP, Sze DM, Roufogalis BD. Molecular and cellular regulators of cancer angiogenesis. Curr Cancer Drug Targets 2007; 7(8): 743-758. https://doi.org/10.2174/156800907783220462
- Ju J, Zhu AJ, Yuan P. Progress in targeted therapy for breast cancer. Chronic Dis Transl Med 2018; 4(3): 164-175. https://doi.org/10.1016/j.cdtm.2018.04.002